Mabpharm Ltd. (2181)
Market Closed
13 Aug, 08:00
HKEX HKEX Primary 0. 42
HKD +0.01
+2.439%
2.14B Market Cap
- P/E Ratio
- Div Yield
20,000 Volume
- Eps
0.41 HKD
Previous Close Want to track 2181 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mabpharm Ltd. (2181) Statistics
Valuation metrics
Market Cap 2.14B
Enterprise value 1.65B
Trailing P/E (ttm) 25.57
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 2.24
Price/Book (mrq) 9.11
Enterprise Value/Revenue 2.58
Enterprise Value/EBITDA 26.9
Overview
Shares outstanding 4.12B
Float 941.28M
Shares short -
% Held by insiders 0.59%
% Held by institutions 0.18%
Average volume (10 days) 48.5K
Average volume (90 days) 281.58K
Price summary
52-Week low 0.31
52-Week high 0.88
Beta 0.61
50-Day moving average 0.41
200-Day moving average 0.46
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.09%
Operating margin 0.01%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.44%
Income Statement
Revenue (ttm) 743.22M
Revenue per share (ttm) 0.16
Quarterly revenue growth (yoy) 1.48%
Gross profit (ttm) 659.89M
EBITDA 74.81M
Net income to common (ttm) 65.72M
Diluted EPS (ttm) 0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 125.68M
Total cash per share (mrq) 0.03
Total debt (mrq) 375.86M
Total Debt/Equity (mrq) 2.08
Current ratio (mrq) 0.81%
Book value per share (mrq) 0.04
Cash Flow
Cash flow statement 92.93M
Levered free cash flow (LFCF) 125.67K
